Establishment of a lymphoblastoid cell line using a mutant MDV containing a green fluorescent protein expression cassette

Acta Virologica

Volumn 43, Issue 2-3, 1999, Pages 106-112

  Dienglewicz, R L ^a   Parcells, M S ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Cell lines; Latency; MDV; Mutagenesis; Mutants

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; GREEN FLUORESCENT PROTEIN; IDOXURIDINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN;

ANIMAL CELL; AVIAN LYMPHOMATOSIS HERPETOVIRUS; CARCINOGENICITY; CONFERENCE PAPER; CYTOTOXICITY; GENE CASSETTE; LYMPHOBLASTOID CELL LINE; NONHUMAN; PROTEIN EXPRESSION; VIRUS GENOME; VIRUS INFECTION; VIRUS MUTATION; VIRUS REACTIVATION;

ANIMALS; BLOTTING, SOUTHERN; CELL LINE, TRANSFORMED; CHICKENS; FEMALE; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HERPESVIRUS 2, GALLID; LUMINESCENT PROTEINS; LYMPHOCYTES; LYMPHOMA; MAREK DISEASE; MICROSCOPY, FLUORESCENCE; MUTAGENESIS, INSERTIONAL; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS; VIRUS ACTIVATION; VIRUS LATENCY;

ANIMALIA; AVES; DNA VIRUSES; GALLID HERPESVIRUS 2; HERPETOVIRUS; MARDIVIRUS;

EID: 0032994080     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Anderson AS, Parcells MS, Morgan RW (1998): The glycoprotein D (US6) homolog is not essential for oncogenicity or horizontal transmission of Marek's disease virus. J. Virol. 72, 2548-2553.
2. Baigent SJ, Ross LJN, Davison TF (1996): A flow cytometric method for identifying Marek's disease virus pp38 expression in lymphocyte subpopulations. Avian Pathol. 25, 255-267.
3. Bradley G, Hayashi M, Lancz G, Tanaka A, Nonoyama M (1989): Structure of the Marek's disease virus BamHI-H gene family: genes of putative importance for tumor induction. J. Virol. 63, 2534-2542.
4. Brunovskis P, Chen X, Velicer L (1992): Analysis of Marek's disease virus glycoproteins D, I, and E. Proc. 4th Int. Symp. Marek's Dis., Ponsen & Looijen, Wageningen, pp. 118-122.
5. s-encoded polypeptides. Proc. 4th Int. Symp. Marek's Dis., Ponsen & Looijen, Wageningen, pp. 74-78.
6. Calnek BW (1985): Marek's disease virus and lymphoma. In Rapp F (Ed.): Oncogenic Herpesviruses. Vol. 1. pp. 103-143.
7. Calnek BW, Shek WR, Schat KA (1981): Spontaneous and induced herpesvirus genome expression in Marek's disease tumor cell lines. Infect. Immun. 34, 483-492.
8. Calnek BW, Witter RL (1997): Marek's disease. In Calnek BW, Witter RL (Ed.): Diseases of Poultry., 10th ed. Iowa State University Press, pp. 367-413.
9. Cantello JL, Anderson AS, Francesconi A, Morgan R W (1991): Isolation of a Marek's disease virus (MDV) recombinant containing the lacZ gene of Escherichia coli stably inserted within the MDV US2 gene. J. Virol. 65, 1585-1588.
10. Chen X, Sondermeijer PJA, Velicer LF (1992): Identification of a unique Marek's disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed in both lytically infected cells and latently infected lymphoblastoid tumor cells. J. Virol. 66, 85-94.
11. Cui Z, Lee LF, Liu J-L, Kung, H-J (1991): Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells. J. Virol. 65, 6509-6515.
12. Dunn K, Nazerian K (1977): Induction of Marek's disease virus antigens by IdUrd in a chicken lymphoblastoid cell lines. J. Gen. Virol. 34, 413-419.
13. Fukuchi K, Sudo M, Lee Y-S, Tanaka A, Nonoyama M (1984): Structure of the Marek's disease virus DNA: detailed restriction enzyme map. J. Virol. 51, 102-109.
14. Göbel TWF (1996): In Davison TF, Morris TR, Payne LN, (Eds): Poultry Immunology. Carfax Publishing Co., Oxfordshire, pp. 31-45.
15. Hirai K, Ikuta K, Kitamoto N, Kato S (1981): Latency of herpesvirus of turkey and Marek's disease virus genomes in a chicken T-lymphoblastoid cell line. J. Gen. Virol. 53, 133-143.
16. Hong Y, Coussens PM (1994): Identification of an immediate-early gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide. J. Virol. 68, 3593-3603.
17. Hong Y, Frame M, Coussens PM (1995): A 14-kDa immediate-early phosphoprotein is specifically expressed in cells infected with oncogenic Marek's disease virus strains and their attenuated derivatives. Virology 206, 695-700.
18. Ikuta K, Nakajima K, Naito M, Ann SH, Ueda S, Kato S, Hirai K (1985): Identification of Marek's disease virus-specific antigens in Marek's disease lymphoblastoid cell lines using monoclonal antibody against virus-specific phosphorylated polypeptides. Int. J. Cancer 35, 257-264.
19. Jones D, Brunovskis P, Witter R, Kung H-J (1996): Retroviral insertional activation of Us genes by an integrated long terminal repeat in a Marek's disease virus clone. J. Virol. 70, 2460-2467.
20. Jones D, Lee L, Liu J-L, Kung H-J, Tillotson JK (1992): Marek's disease encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc. Natl. Acad. Sci. USA 89, 4042-4046.
21. Maray T, Malkinson M, Becker Y (1988): RNA transcripts of Marek's disease virus (MDV) serotype-1 infected and transformed cells. Virus Genes 2, 49-68.
22. Morgan RW, Anderson A, Kent J, Parcells M (1996): Characterization of Marek's disease virus RB1B-based mutants having disrupted glycoprotein C or glycoprotein D homolog genes. Proc. 5th Int. Symp. Marek's Dis., Rose Printing Co., Inc., Tallahassee, pp. 207-212.
23. Nakajima K, Ikuta K, Naito M, Ueda S, Kato S, Hirai K (1987): Analysis of Marek's disease virus serotype 1-specific phosphorylated polypeptides in virus-infected cells and Marek's disease lymphoblastoid cells. J. Gen. Virol. 68, 1379-1389.
24. Nazerian KJ, Sharma JM (1975): Detection of T-cell surface antigens in a Marek's disease lymphoblastoid cell line. J. Natl. Cancer Inst. 54, 277-279.
25. Parcells MS, Anderson AS, Cantello JL, Morgan RW (1994a): Characterization of Marek's disease virus insertion and deletion mutants that lack US1 (ICP22 homolog), US10, and/or US2 and neighboring short component open reading frames. J. Virol. 68, 8239-8253.
26. Parcells MS, Anderson AS, Morgan RW (1994b): Characterization of a Marek's disease virus mutant containing a lacZ insertion in the US6 (gD) homologue gene. Virus Genes 9, 5-13.
27. Parcells MS, Anderson AS, Morgan RW (1995): Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes. J. Virol. 69, 7888-7898.
28. Parcells MS, Anderson AS, Morgan RW (1996): Rapid construction of mutant Marek's disease viruses using a green fluorescent protein (GFP) expression cassette. Proc. 5th Int. Symp. Marek's Dis., Rose Printing Co., Inc., Tallahassee, pp. 284-289.
29. Parcells MS, Dienglewicz RL, Anderson AS, Morgan RW (1998): Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome. J. Virol. 73, 1362-1373.
30. Peng F, Bradley G, Tanaka A, Lancz G, Nonoyama M (1992): Isolation and characterization of cDNAs from BamHI-H gene family RNAs associated with the tumorigenicity of Marek's disease virus. J. Virol. 66, 7389-7396.
31. Peng F, Specter S, Tanaka A, Nonoyama M (1994): A 7 kDa protein encoded by the BamHI-H gene family of Marek's disease virus is produced in lytically and latently infected cells. Int. J. Oncology 4, 799-802.
32. Powell PC (1975): T lymphoblastoid cell lines from Marek's disease lymphomas. Nature 251, 79-80.
33. Sambrook J, Fritsch EF, Maniatis T (1989): Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor.
34. Schat KA, Calnek BW, Fabricant J (1982): Characterization of two highly oncogenic strains of Marek's disease virus. Avian Pathol. 11, 593-605.
35. Schat KA, Chen C-L, Shek WR, Calnek BW (1982): Surface antigens on Marek's disease lymphoblastoid cell lines. J. Natl. Cancer Inst. 69, 715-720.
36. Schat KA, Chen C-LH, Calnek BW, Char D (1991): Transformation of T lymphocyte subsets by Marek's disease herpesvirus. J. Virol. 65, 1408-1413.
37. Schat KA, Pratt WD, Morgan R, Weinstock D, Calnek BW (1992): Stable transfection of reticuloendotheliosis virus-transformed lymphoblastoid cell lines. Avian Dis. 36, 432-439.
38. Silver S, Smith M, Nonoyama M (1979): Transcription of the Marek's disease virus genome in virus-induced tumors. J. Virol. 30, 84-89.
39. Venugopal K, Payne LN (1995): Molecular pathogenesis of Marek's disease - recent developments. Avian Pathol. 24, 597-609.